Κλαύδιος Γαληνός
Δωρεάν εγγραφή Αποκτήσετε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr για έναν μήνα
Έλεγχος συγχορήγησης Ελέγξτε την αγωγή σας για αντενδείξεις και αλληλεπιδράσεις μεταξύ των φαρμάκων
Μητρότητα και φάρμακα Ενημερωθείτε για την ασφάλεια χορήγησης ενός φαρμάκου κατά τη διάρκεια της εγκυμοσύνης ή του θηλασμού
Συνδρομές Μάθετε περισσότερα για τα οφέλη και τις επιπλέον παροχές των συνδρομητικών προγραμμάτων
Ενδείξεις και αγωγές Βρείτε θεραπευτικές ενδείξεις και αγωγές για νόσους, συμπτώματα και ιατρικές πράξεις
Γνωρίζατε ότι... Μοιραζόμαστε μαζί σας γεγονότα της πορείας του Galinos.gr από το 2011 μέχρι σήμερα

DEHYDRATED ALCOHOL Solution for injection (2008)

Αναφορές

Βιβλιογραφική αναφορά

Για την προβολή της πλήρους καταχώρησης απαιτείται συνδρομή σε ισχύ.
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή

Περιεχόμενα

Name of the medicinal product

Dehydrated Alcohol (Absolute Alcohol) BP for Injection.

Qualitative and quantitative composition

Ethanol BP 100% v/v.

Pharmaceutical form

Solution for injection.

Therapeutic indications

Severe and chronic pain including that caused by trigeminal neuralgia may be relieved by injection of alcohol close to the nerve. Alcohol is given intravenously in the treatment of acute poisoning from ...

Posology and method of administration

Severe pain including trigeminal neuralgia 0.2ml, for a small nerve root to a maximum of 10ml for blockade of the coeliac ganglion. Injected into the individual nerve root or ganglion. The needle tip should ...

Contraindications

Known hypersensitivity to alcohol.

Special warnings and precautions for use

Women and the elderly may be more susceptible to the adverse effects of alcohol ingestion. Unpleasant reactions, similar to those occurring with disulfiram may occur when alcohol is taken concomitantly ...

Interaction with other medicinal products and other forms of interaction

Alcohol may enhance the acute effects of drugs which depress the central nervous system, such as hypnotics, antihistamines, muscle relaxants, opioid analgesics, antiepileptics, antidepressants, and tranquillisers. ...

Pregnancy and lactation

Studies indicate the oral use of alcohol during first and second trimesters can have serious effects upon the foetus, including low birth weight. Use of alcohol during third trimester can cause withdrawal ...

Effects on ability to drive and use machines

All processes requiring judgement and co-ordination are affected by alcohol and these include the driving of any form of transport and the operating of machinery.

Undesirable effects

Effects of alcohol at higher concentrations may include; nausea, vomiting, headache, dizziness and tremor. Alcohol depresses medullary action causing lethargy, amnesia, hypothermia, hypoglycaemia (especially ...

Overdose

Symptoms Acute toxicity is primarily one of CNS depression. Treatment In acute poisoning the stomach may be emptied by aspiration and lavage if indicated. If respiration is depressed, assisted respiration ...

Pharmacodynamic properties

Primary and continuous depressant of the central nervous system. It has a depressant action on the vasomotor-centre. Subcutaneous tissues Alcohol injected hypodermically causes considerable pain followed ...

Pharmacokinetic properties

Alcohol is rapidly distributed throughout the body. It readily crosses the placenta. Alcohol is mainly metabolised in the liver and is converted by alcohol dehydrogenase to acetaldehyde and is then further ...

Preclinical safety data

There are no additional data of relevance to the prescriber.

List of excipients

Not applicable.

Incompatibilities

None stated.

Shelf life

Shelf life: 60 months (unopened).

Special precautions for storage

None stated.

Nature and contents of container

Colourless ampoules of neutral glass packed into cartons of 10 ampoules, containing 2ml, 5ml, 10ml, 20ml, or 50ml of solution.

Special precautions for disposal and other handling

None stated.

Marketing authorization holder

Macarthys Laboratories Limited, T/A Martindale Pharmaceuticals, Bampton Road, Harold Hill, Romford, RM3 8UG

Marketing authorization number(s)

PL 01883/6119R

Date of first authorization / renewal of the authorization

24/09/2007

Date of revision of the text

12/03/2008

Πηγαίο έγγραφο

Το πηγαίο έγγραφο για αυτήν την βιβλιογραφική αναφορά είναι διαθέσιμο προς μεταφόρτωση:

Μπορείτε να υποστηρίξετε τον Γαληνό στην αποστολή του να παρέχει δωρεάν έγκυρη πληροφόρηση για κάθε φάρμακο απενεργοποιώντας το Ad Blocker για αυτόν τον ιστότοπο.